• Something wrong with this record ?

Acute exposure to long-chain fatty acids impairs {alpha}2-adrenergic receptor-mediated antilipolysis in human adipose tissue

J Polak, C Moro, D Bessiere, J Hejnova, MA Marques, M Bajzova, M Lafontan, F Crampes, M Berlan, V Stich

. 2007 ; 48 (10 Oct) : 2236-2246.

Language English Country United States

The acute in vitro and in vivo effects of long-chain fatty acids (LCFAs) on the regulation of adrenergic lipolysis were investigated in human adipose tissue. The effect of a 2 h incubation, without or with LCFA (200 mumol/l), on basal and hormonally induced lipolysis was tested in vitro on isolated fat cells. The lipolytic response to epinephrine was enhanced by suppression of the antilipolytic alpha(2)-adrenergic effect. Then, healthy lean and obese male subjects performed a 45 min exercise bout at 50% of their heart rate reserve either after an overnight fast or 3 h after a high-fat meal (HFM: 95% fat, 5% carbohydrates). Subcutaneous adipose tissue lipolysis was measured by microdialysis in the presence or absence of an alpha-antagonist (phentolamine). In vivo, a HFM increased plasma levels of nonesterified fatty acids in lean and obese subjects. In both groups, the HFM did not alter hormonal responses to exercise. Under fasting conditions, the alpha(2)-adrenergic antilipolytic effect was more pronounced in obese than in lean subjects. The HFM totally suppressed the alpha(2)-adrenergic antilipolytic effect in lean and obese subjects during exercise. LCFAs per se, in vitro as well as in vivo, suppress alpha(2)-adrenergic-mediated antilipolysis in adipose tissue. LCFA-mediated suppression of antilipolytic pathways represents another mechanism whereby a high fat content in the diet might increase adipose tissue lipolysis.

000      
03286naa 2200493 a 4500
001      
bmc10012720
003      
CZ-PrNML
005      
20121113100420.0
008      
100526s2007 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Polák, Jan $7 xx0102455
245    10
$a Acute exposure to long-chain fatty acids impairs {alpha}2-adrenergic receptor-mediated antilipolysis in human adipose tissue / $c J Polak, C Moro, D Bessiere, J Hejnova, MA Marques, M Bajzova, M Lafontan, F Crampes, M Berlan, V Stich
314    __
$a Franco-Czech Laboratory for Clinical Research on Obesity, French Institute of Health and Medical Research (Institut National de la Sante et de la Recherche Medicale U858), Charles University in Prague, Prague, Czech Republic.
520    9_
$a The acute in vitro and in vivo effects of long-chain fatty acids (LCFAs) on the regulation of adrenergic lipolysis were investigated in human adipose tissue. The effect of a 2 h incubation, without or with LCFA (200 mumol/l), on basal and hormonally induced lipolysis was tested in vitro on isolated fat cells. The lipolytic response to epinephrine was enhanced by suppression of the antilipolytic alpha(2)-adrenergic effect. Then, healthy lean and obese male subjects performed a 45 min exercise bout at 50% of their heart rate reserve either after an overnight fast or 3 h after a high-fat meal (HFM: 95% fat, 5% carbohydrates). Subcutaneous adipose tissue lipolysis was measured by microdialysis in the presence or absence of an alpha-antagonist (phentolamine). In vivo, a HFM increased plasma levels of nonesterified fatty acids in lean and obese subjects. In both groups, the HFM did not alter hormonal responses to exercise. Under fasting conditions, the alpha(2)-adrenergic antilipolytic effect was more pronounced in obese than in lean subjects. The HFM totally suppressed the alpha(2)-adrenergic antilipolytic effect in lean and obese subjects during exercise. LCFAs per se, in vitro as well as in vivo, suppress alpha(2)-adrenergic-mediated antilipolysis in adipose tissue. LCFA-mediated suppression of antilipolytic pathways represents another mechanism whereby a high fat content in the diet might increase adipose tissue lipolysis.
650    _2
$a tuková tkáň $x metabolismus $7 D000273
650    _2
$a dospělí $7 D000328
650    _2
$a dietní tuky $7 D004041
650    _2
$a mastné kyseliny $x metabolismus $7 D005227
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a potraviny $7 D005502
650    _2
$a lidé $7 D006801
650    _2
$a inzulin $x metabolismus $7 D007328
650    _2
$a lipolýza $7 D008066
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikrodialýza $7 D017551
650    _2
$a lidé středního věku $7 D008875
650    _2
$a obezita $7 D009765
650    _2
$a fentolamin $x farmakologie $7 D010646
650    _2
$a alfa-2-adrenergní receptory $x metabolismus $7 D018341
650    _2
$a financování organizované $7 D005381
700    1_
$a Moro, Cedric
700    1_
$a Bessiere, David
700    1_
$a Hejnová, Jindra, $d 1947- $7 nlk20040147074
700    1_
$a Marques, Marie A.
700    1_
$a Bajzová, Magda, $d 1981- $7 xx0065865
700    1_
$a Lafontan, Max
700    1_
$a Crampes, Francois
700    1_
$a Berlan, Michel
700    1_
$a Štich, Vladimír, $d 1946- $7 xx0050390
773    0_
$t Journal of Lipid Research $w MED00002766 $g Roč. 48, č. 10 Oct (2007), s. 2236-2246 $x 0022-2275
910    __
$a ABA008 $b x $y 8
990    __
$a 20100531141815 $b ABA008
991    __
$a 20121113100435 $b ABA008
999    __
$a ok $b bmc $g 726575 $s 589732
BAS    __
$a 3
BMC    __
$a 2007 $b 48 $c 10 Oct $d 2236-2246 $i 0022-2275 $m Journal of lipid research $n J Lipid Res $x MED00002766
LZP    __
$a 2010-B2/vtme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...